 | • レポートコード：MRC2-11QY12234 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は院内感染治療のグローバル市場について調査・分析したレポートです。種類別（抗菌薬、抗ウイルス薬、抗真菌薬）市場規模、用途別（院内肺炎、手術部位感染症、尿路感染症、消化器疾患、菌血症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別院内感染治療の競争状況、市場シェア ・世界の院内感染治療市場：種類別市場規模 2015年-2020年（抗菌薬、抗ウイルス薬、抗真菌薬） ・世界の院内感染治療市場：種類別市場規模予測 2021年-2026年（抗菌薬、抗ウイルス薬、抗真菌薬） ・世界の院内感染治療市場：用途別市場規模 2015年-2020年（院内肺炎、手術部位感染症、尿路感染症、消化器疾患、菌血症、その他） ・世界の院内感染治療市場：用途別市場規模予測 2021年-2026年（院内肺炎、手術部位感染症、尿路感染症、消化器疾患、菌血症、その他） ・北米の院内感染治療市場分析：米国、カナダ ・ヨーロッパの院内感染治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの院内感染治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の院内感染治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの院内感染治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Johnson & Johnson Services、Actavis、Sanofi、Bristol Myers Squibb Company、AstraZeneca、Pfizer、Merck、GlaxoSmithkline、Cubist Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
Market Analysis and Insights: Global Hospital Infection Therapeutics Market
The global Hospital Infection Therapeutics market size is projected to reach US$ 2797.4 million by 2026, from US$ 2724.5 million in 2020, at a CAGR of 2.5%% during 2021-2026.
Global Hospital Infection Therapeutics Scope and Market Size
Hospital Infection Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Infection Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Market segment by Type, the product can be split into
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Market segment by Application, split into
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Infection Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibacterial Drugs
1.4.3 Antiviral Drugs
1.4.4 Antifungal Drugs
1.5 Market by Application
1.5.1 Global Hospital Infection Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Acquired Pneumonia
1.5.3 Surgical Site Infections
1.5.4 Urinary Tract Infection
1.5.5 Gastrointestinal Disorders
1.5.6 Bloodstream Infections
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Therapeutics Market Perspective (2015-2026)
2.2 Global Hospital Infection Therapeutics Growth Trends by Regions
2.2.1 Hospital Infection Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Infection Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Infection Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Infection Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Infection Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Infection Therapeutics Players by Market Size
3.1.1 Global Top Hospital Infection Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Infection Therapeutics Market Concentration Ratio
3.2.1 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Infection Therapeutics Revenue in 2019
3.3 Hospital Infection Therapeutics Key Players Head office and Area Served
3.4 Key Players Hospital Infection Therapeutics Product Solution and Service
3.5 Date of Enter into Hospital Infection Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Infection Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Hospital Infection Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Infection Therapeutics Market Size by Application (2015-2020)
5.2 Global Hospital Infection Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Infection Therapeutics Market Size (2015-2020)
6.2 Hospital Infection Therapeutics Key Players in North America (2019-2020)
6.3 North America Hospital Infection Therapeutics Market Size by Type (2015-2020)
6.4 North America Hospital Infection Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Infection Therapeutics Market Size (2015-2020)
7.2 Hospital Infection Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Hospital Infection Therapeutics Market Size by Type (2015-2020)
7.4 Europe Hospital Infection Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Hospital Infection Therapeutics Market Size (2015-2020)
8.2 Hospital Infection Therapeutics Key Players in China (2019-2020)
8.3 China Hospital Infection Therapeutics Market Size by Type (2015-2020)
8.4 China Hospital Infection Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Infection Therapeutics Market Size (2015-2020)
9.2 Hospital Infection Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Hospital Infection Therapeutics Market Size by Type (2015-2020)
9.4 Japan Hospital Infection Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Infection Therapeutics Market Size (2015-2020)
10.2 Hospital Infection Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Infection Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Infection Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Hospital Infection Therapeutics Market Size (2015-2020)
11.2 Hospital Infection Therapeutics Key Players in India (2019-2020)
11.3 India Hospital Infection Therapeutics Market Size by Type (2015-2020)
11.4 India Hospital Infection Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Infection Therapeutics Market Size (2015-2020)
12.2 Hospital Infection Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Infection Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Hospital Infection Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Hospital Infection Therapeutics Introduction
13.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Johnson & Johnson Services
13.2.1 Johnson & Johnson Services Company Details
13.2.2 Johnson & Johnson Services Business Overview
13.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Introduction
13.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.2.5 Johnson & Johnson Services Recent Development
13.3 Actavis
13.3.1 Actavis Company Details
13.3.2 Actavis Business Overview
13.3.3 Actavis Hospital Infection Therapeutics Introduction
13.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.3.5 Actavis Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Hospital Infection Therapeutics Introduction
13.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Bristol Myers Squibb Company
13.5.1 Bristol Myers Squibb Company Company Details
13.5.2 Bristol Myers Squibb Company Business Overview
13.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Introduction
13.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.5.5 Bristol Myers Squibb Company Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview
13.6.3 AstraZeneca Hospital Infection Therapeutics Introduction
13.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.6.5 AstraZeneca Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Hospital Infection Therapeutics Introduction
13.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Hospital Infection Therapeutics Introduction
13.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.8.5 Merck Recent Development
13.9 GlaxoSmithkline
13.9.1 GlaxoSmithkline Company Details
13.9.2 GlaxoSmithkline Business Overview
13.9.3 GlaxoSmithkline Hospital Infection Therapeutics Introduction
13.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.9.5 GlaxoSmithkline Recent Development
13.10 Cubist Pharmaceuticals
13.10.1 Cubist Pharmaceuticals Company Details
13.10.2 Cubist Pharmaceuticals Business Overview
13.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Introduction
13.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2015-2020)
13.10.5 Cubist Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hospital Infection Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital Infection Therapeutics Revenue
Table 3. Ranking of Global Top Hospital Infection Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibacterial Drugs
Table 6. Key Players of Antiviral Drugs
Table 7. Key Players of Antifungal Drugs
Table 8. Global Hospital Infection Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hospital Infection Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hospital Infection Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hospital Infection Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Hospital Infection Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hospital Infection Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Hospital Infection Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Hospital Infection Therapeutics Players
Table 19. Global Hospital Infection Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Hospital Infection Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Infection Therapeutics as of 2019)
Table 22. Global Hospital Infection Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hospital Infection Therapeutics Product Solution and Service
Table 25. Date of Enter into Hospital Infection Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Hospital Infection Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Hospital Infection Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Hospital Infection Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Hospital Infection Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 35. North America Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 37. North America Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 41. Europe Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 47. China Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 49. China Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 53. Japan Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 65. India Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 67. India Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Hospital Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Hospital Infection Therapeutics Market Share (2019-2020)
Table 71. Central & South America Hospital Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Hospital Infection Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Hospital Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Hospital Infection Therapeutics Market Share by Application (2015-2020)
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Product
Table 78. Bayer Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 79. Bayer Recent Development
Table 80. Johnson & Johnson Services Company Details
Table 81. Johnson & Johnson Services Business Overview
Table 82. Johnson & Johnson Services Product
Table 83. Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Services Recent Development
Table 85. Actavis Company Details
Table 86. Actavis Business Overview
Table 87. Actavis Product
Table 88. Actavis Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 89. Actavis Recent Development
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Product
Table 93. Sanofi Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 94. Sanofi Recent Development
Table 95. Bristol Myers Squibb Company Company Details
Table 96. Bristol Myers Squibb Company Business Overview
Table 97. Bristol Myers Squibb Company Product
Table 98. Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 99. Bristol Myers Squibb Company Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Product
Table 103. AstraZeneca Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 104. AstraZeneca Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. Merck Business Overview
Table 111. Merck Product
Table 112. Merck Company Details
Table 113. Merck Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 114. Merck Recent Development
Table 115. GlaxoSmithkline Company Details
Table 116. GlaxoSmithkline Business Overview
Table 117. GlaxoSmithkline Product
Table 118. GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 119. GlaxoSmithkline Recent Development
Table 120. Cubist Pharmaceuticals Company Details
Table 121. Cubist Pharmaceuticals Business Overview
Table 122. Cubist Pharmaceuticals Product
Table 123. Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2015-2020) (Million US$)
Table 124. Cubist Pharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Infection Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antibacterial Drugs Features
Figure 3. Antiviral Drugs Features
Figure 4. Antifungal Drugs Features
Figure 5. Global Hospital Infection Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Acquired Pneumonia Case Studies
Figure 7. Surgical Site Infections Case Studies
Figure 8. Urinary Tract Infection Case Studies
Figure 9. Gastrointestinal Disorders Case Studies
Figure 10. Bloodstream Infections Case Studies
Figure 11. Others Case Studies
Figure 12. Hospital Infection Therapeutics Report Years Considered
Figure 13. Global Hospital Infection Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Hospital Infection Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Hospital Infection Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Hospital Infection Therapeutics Market Share by Players in 2019
Figure 18. Global Top Hospital Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Infection Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Hospital Infection Therapeutics Revenue in 2019
Figure 20. North America Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Hospital Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 院内肺炎（HAP）治療薬の世界市場（～2026年） HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects …
- サイトメガロウイルス（HHV-5）感染症治療薬の世界市場（～2026年） A drug used to treat giant cell infections. Market Analysis and Insights: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…
- 院内肺炎治療薬の世界市場（～2026年） Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus. Market An…